This section describes our partnerships, collaborations, and other affiliations.
- UCSF - the leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
- UCSF Department of Cellular and Molecular Pharmacology - discovers knowledge through innovative research on chemical and biological phenomena.
- UCSF Department of Pharmaceutical Chemistry - focuses on understanding fundamental biochemical mechanisms underlying health and disease, which are key to developing new and more effective diagnostics and medications.
- UCSF School of Medicine - striving to advance human health through a fourfold mission of education, research, patient care, and public service.
- UCSF School of Pharmacy - focused on improving health through precise therapeutics—medicines, medical devices, and diagnostic tests.
- UCSF Antibiome Center - devoted to identification and generation of recombinant antibodies at a proteome-wide scale.
- UCSF Biophysics Graduate Program - a PhD program that prepares scientists to leverage new and emerging research tools—from nanotechnology to nuclear magnetic resonance spectroscopy—to quantify biological processes in living biological systems using physics and chemistry.
- UCSF Chemistry and Chemical Biology Graduate Program (CCB) - a PhD program that prepares scientists to address problems at the intersection of chemistry and biology by providing a chemical foundation for understanding complex biological processes at an atomic level.
- UCSF Helen Diller Family Comprehensive Cancer Center - combines basic science, clinical research, epidemiology/cancer control and patient care from throughout the University of California, San Francisco system.
- UCSF Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG) - focuses on how to develop effective drug therapies for patients that have a minimum of adverse effects.
- UCSF Small Molecule Discovery Center (SMDC) - collaborates with academics, government labs, and pharmaceutical companies to develop unique chemical probes and leads for important targets that address unmet medical needs.
- UCSF TETRAD Graduate Program - offers diverse training and opportunities in four major research areas: biochemistry and molecular biology, cell biology, developmental biology, and genetics. The program is interdisciplinary, with an emphasis on collaborations among laboratories to solve outstanding problems in modern biology.
- Chan Zuckerberg Biohub - combining the best scientists and engineers with the most advanced technology to solve the world’s biggest health problems.
- Parker Institute for Cancer Immunotherapy - enabling real collaboration and accelerating ambitious research to deliver new immunotherapies engineered to save lives.
- QB3/QBI - a nonprofit research and technology commercialization institute spanning three University of California campuses in the San Francisco Bay Area (UC Berkeley, UCSF, and UC Santa Cruz) focusing on the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.
- Recombinant Antibody Network (RAN) - a consortium of highly integrated technology centers at UCSF, the University of Chicago, and the University of Toronto, unified under a common goal to generate therapeutic-grade recombinant antibodies at a proteome-wide scale for biology and biomedicine.